{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/leg-ulcer-venous/diagnosis/differential-diagnosis/","result":{"pageContext":{"chapter":{"id":"0c766f2c-0c8f-521b-85fd-e947ba6b2d09","slug":"differential-diagnosis","fullItemName":"Differential diagnosis","depth":2,"htmlHeader":"<!-- begin field ccf316b3-88ae-41a2-8d0e-b05d13f667ef --><h2>What else might it be?</h2><!-- end field ccf316b3-88ae-41a2-8d0e-b05d13f667ef -->","summary":"","htmlStringContent":"<!-- begin item fa965d4d-f666-4648-add4-bec44d881052 --><!-- begin field 69deb4fe-058d-407c-bd41-7f2f917029f7 --><ul><li><strong>Exclude the following conditions in the initial assessment of a person with a suspected venous leg ulcer: </strong><ul><li><strong>Peripheral arterial disease</strong> — ulcers due to arterial disease often appear well demarcated and have a 'punched out' appearance. There may be signs of arterial compromise, such as pallor, loss of hair, nail dystrophy, coldness, and diminished capillary refill. A history of intermittent claudication, cardiovascular disease, or stroke may indicate the presence of arterial disease. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/peripheral-arterial-disease/\">Peripheral arterial disease</a> for more information.</li><li><strong>Rheumatoid arthritis </strong>— rheumatoid ulcers may be venous, arterial, or vasculitic. Vasculitic ulcers can occur on the calf or dorsum of the foot and are typically deep and well demarcated with a 'punched out' appearance.<strong> </strong>People with vasculitic ulcers will have clinical features of established disease which may be associated with systemic vasculitis. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/rheumatoid-arthritis/\">Rheumatoid arthritis</a> for more information.</li><li><strong>Systemic vasculitis </strong>— people with systemic vasculitis often develop multiple leg ulcers that are necrotic and deep. There is usually an atypical distribution and evidence of vasculitic lesions elsewhere (for example nail-fold infarcts and splinter haemorrhages). Associated conditions include systemic lupus erythematosus, scleroderma, polyarteritis nodosa, and Wegener's granulomatosis. </li><li><strong>Diabetes mellitus </strong>— diabetic ulcers may be venous, arterial, or neuropathic. Neuropathic ulcers typically develop under calluses or over pressure points, such as metatarsal heads, sole of foot, and balls of toes. They are often irregular and correspond to the shape of the pressure point that has become exposed. The edge and base are often clean and may be deep, with exposure of bone and tendon. People with diabetes may also have diabetic bullae or necrobiosis lipoidica, both of which can ulcerate. </li><li><strong>Malignancy</strong> — malignant ulcers often occur in sun exposed areas. The ulcer edge may be rolled (basal cell carcinoma) or everted (squamous cell carcinoma). Malignancy should be considered if the ulcer does not respond to medical treatment or if the appearance is unusual. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/skin-cancers-recognition-referral/\">Skin cancers - recognition and referral</a> for more information.</li></ul></li><li><strong>Other types of lower limb ulcers include:</strong><ul><li><strong>Pressure ulcers </strong>— caused by unrelieved pressure over bony prominences, such as the malleolus or the heel. Prolonged compression of the tissues, along with friction and shear, results in local tissue ischemia, necrosis, and ulcer formation.</li><li><strong>Drug/treatment-induced ulcers </strong>— certain drugs/treatments can:<ul><li>Cause ulceration, for example nicorandil, hydroxycarbamide, and radiotherapy.</li><li>Delay wound healing, for example hydroxycarbamide, immunosuppressive drugs, antipsychotics, beta-blockers, nicorandil, corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), anticoagulants, and radiotherapy.</li><li>Increase oedema, for example calcium channel blockers (such as amlodipine) and NSAIDs. </li><li>Affect surrounding skin, for example systemic and topical corticosteroids, and radiotherapy.</li></ul></li><li><strong>Others</strong> — tropical ulcers, tuberculosis ulcers, syphilitic ulcers, and ulcers caused by sarcoidosis, pyoderma gangrenosum, livedoid vasculopathy, and sickle cell disease. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/tuberculosis/\">Tuberculosis</a>, <a class=\"topic-reference external-reference\" href=\"/topics/sickle-cell-disease/\">Sickle cell disease</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/syphilis/\">Syphilis</a> for more information.</li></ul></li></ul><!-- end field 69deb4fe-058d-407c-bd41-7f2f917029f7 --><!-- end item fa965d4d-f666-4648-add4-bec44d881052 -->","topic":{"id":"627b2b3c-014b-5543-8f89-0f3ffa6344ad","topicId":"4c5db985-9544-48b2-8c54-8915ec210739","topicName":"Leg ulcer - venous","slug":"leg-ulcer-venous","lastRevised":"Last revised in January 2021","chapters":[{"id":"01818c5e-efb9-59c4-b339-08b834294232","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"313e84c5-8bc7-5150-826a-467ea7252acd","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2597db24-8ec5-54d4-86ad-8082be50f4f6","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"38f24092-0019-582d-86bf-d1f61bccde1d","slug":"changes","fullItemName":"Changes"},{"id":"cdc15e74-0503-53a5-a4be-c53ec4e20898","slug":"update","fullItemName":"Update"}]},{"id":"73d0cf59-f9c0-5785-8c74-e756826d5d1e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"64b11689-d52a-560f-8d9b-c592d654615e","slug":"goals","fullItemName":"Goals"},{"id":"ac3d1637-467f-5edb-8fd8-73f66160080f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4bffe5b2-0ce0-5ae8-8c0b-914bb6ed5a1d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"82441da5-60f5-53b4-b510-187f7bacb4a8","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3e5817d5-30e7-54b7-b9ba-224b4a295bba","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b30bb006-efbc-5a69-90f3-30abf232a97d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"84dc0da0-8533-5c5d-99f6-7c04a116701a","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"45d8d35d-9757-544c-b04e-9747898a1f0e","slug":"definition","fullItemName":"Definition"},{"id":"21acb832-e5e8-5bd1-9b8d-9410ec5011bf","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"cf27bd7b-b787-5def-bb40-ee0f134a8aca","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a55a1739-f3d2-534c-b533-f6406d9c81ea","slug":"complications","fullItemName":"Complications"},{"id":"683b612a-3f1d-5580-951b-e14672f52b4a","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"dbc94220-a914-56d0-883d-d158da511e1c","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"57b3b7a5-9042-53fa-a236-56d0d02b647e","slug":"assessment","fullItemName":"Assessment"},{"id":"35ee8784-602e-5a29-9ccf-65b3c3f940d2","slug":"interpretation-of-abpi","fullItemName":"Interpretation of ABPI"},{"id":"0c766f2c-0c8f-521b-85fd-e947ba6b2d09","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"5e199f8a-7621-5318-9da1-264db8f544b8","fullItemName":"Management","slug":"management","subChapters":[{"id":"c8bda10b-ebb6-533b-9c91-96efa5ddf0c3","slug":"venous-leg-ulcers","fullItemName":"Scenario: Venous leg ulcers"}]},{"id":"e084faba-a409-53ac-aa53-08b80a3991f1","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"66a7f656-c6f5-57a2-a08a-1533a6fd4e92","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"a6cda703-9039-5115-b3d3-478cdb4d1e55","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"1cf75cbb-8bc4-58cc-9a1b-11516db5ad2c","slug":"co-trimoxazole","fullItemName":"Co-trimoxazole"},{"id":"3f0efc32-779b-56f6-85ca-e46a59745bed","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"fe306aab-d8d7-5181-a461-128f2aa3c65a","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"314a80d5-e16b-5625-8d64-4141535ff392","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"b7e7b8ec-799c-5ea5-9ac0-11935f899b8a","slug":"oral-analgesia","fullItemName":"Oral analgesia"},{"id":"43ed3b03-6322-5690-8f85-b6e10a0b3d3e","slug":"pentoxifylline","fullItemName":"Pentoxifylline"}]},{"id":"19f3ffbe-f365-5196-8586-0dceeaf69908","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"89207239-b8a4-50ce-8b2d-3065a830c0af","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"45831e7c-0e6f-50f3-a513-fe4fcacff65e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3d90cdb0-b2fd-5bfd-bd2d-342e36901f9d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"8b66d1a4-6ee5-5556-b671-204219a81787","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"5b8ee442-8da6-524f-bf34-e6a9cc2a771e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6fa96be3-beae-51f6-9f1c-4d278b058d09","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"e75dc366-237b-55d2-a654-2e3bf503b955","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"dbc94220-a914-56d0-883d-d158da511e1c","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"c1be8898-e1ee-54db-8f4f-cd8ac07cbc9f","slug":"basis-for-recommendation-b52","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 4ce9ed8b-3992-4c71-b5b1-7a861d7c2f29 --><h3>Basis for recommendation</h3><!-- end field 4ce9ed8b-3992-4c71-b5b1-7a861d7c2f29 -->","summary":null,"htmlStringContent":"<!-- begin item b527f58d-0908-4f7f-a6cd-ea29586d3bd7 --><!-- begin field 3367ed6f-6916-4429-9896-9ffb3e3c91d8 --><p>The information on the differential diagnoses of venous leg ulcer is based on the Scottish Intercollegiate Guidelines Network (SIGN) guideline <em>Management of chronic venous leg ulcers</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">SIGN, 2010</a>], the Primary Care Dermatology Society (PCDS) guideline <em>Leg ulcers (and disorders of venous insufficiency)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">PCDS, 2016</a>], a joint document by the European Wound Management Association (EWMA) and Wounds Australia <em>Management of Patients With Venous Leg Ulcers: Challenges and Current Best Practice</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">Franks, 2016</a>], the Wounds UK document <em>Best Practice Statement: Addressing complexities in the management of venous leg ulcers</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">Wounds UK, 2019</a>], and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">Grey et al, 2006a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">Grey et al, 2006b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">Patel et al, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">Vivas, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">Singer, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">Lim, 2018</a>]. </p><!-- end field 3367ed6f-6916-4429-9896-9ffb3e3c91d8 --><!-- end item b527f58d-0908-4f7f-a6cd-ea29586d3bd7 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}